VRTX News
Vertex Pharmaceuticals Incorporated
$498.50
+$13.28(+2.74%)
51
Overall
60
Value
30
Tech
63
Quality
Market Cap
$122.98B
Volume
2.06M
52W Range
$402.58 - $560.25
Target Price
$572.86
VRTX news: the latest Vertex Pharmaceuticals Incorporated headlines, press releases and market updates, newest first.
Latest VRTX News
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Demant (OtherWILLF) and Biomea Fusion (BMEA)TipRanks Newsroom · Oct 15, 2026
- Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 9, 2026
- Vortex Energy Expands Saskatchewan Portfolio with Meadows Project AcquisitionTipRanks Canadian Auto-Generated Newsdesk · Oct 1, 2026
- Citi Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 23, 2026
- Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Celldex (CLDX) and Vertex Pharmaceuticals (VRTX)TipRanks Newsroom · Sep 23, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE)TipRanks Newsroom · Sep 22, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $498.50 | +2.7% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW